Integrin alpha-L (ITGAL or CD11a) Antibody - FFPE Validated

Scientific Overview

For consistent comparison across experiments, use this antibody to evaluate Integrin alpha-L (ITGAL) with a repeatable workflow. Integrin alpha-L is an adhesion-related target that can shift with substrate composition and mechanical cues. Use matched handling so differences reflect biology rather than processing.

In some datasets and protocols, it is referenced by the gene symbol ITGAL.

Research Relevance

Comparative experiments can separate expression differences from changes in adhesion structure abundance. Define inclusion criteria and controls early so replicate sets remain interpretable as the dataset grows.

Because cellular networks are interconnected, changes in this target may coincide with shifts in related pathways, trafficking behavior, or structural remodeling.

When building a narrative around the target, it helps to track:

• focal adhesion versus diffuse membrane distribution
• co-variation with cytoskeletal and scaffold partners
• remodeling after changes in substrate or mechanical stress
• effects of adhesion inhibitors or matrix composition

Application-Specific Context

In sectioned tissue workflows, interpretation often depends on morphology; this format supports that style of readout. Think about how preparation affects epitope accessibility, and interpret patterns alongside morphology and compartment markers as needed. A short pilot series can help set exposure ranges and reduce reruns.

If your study spans multiple model systems, it can help to define a shared reference condition for Integrin alpha-L so cross-sample contrasts stay meaningful.

For multi-run studies, the fixed-section option helps keep Integrin alpha-L (ITGAL) trends comparable from experiment to experiment.